1-4 of 4
Giovanna Rossi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract OT1-04-01: AMEERA-6: Phase 3 Study of Adjuvant Amcenestrant Versus Tamoxifen for Patients With Hormone Receptor-Positive Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity

Otto Metzger, Christina Herold, Coralie Poncet, Heidi De Swert, Jose Casas-Martin, Ann Partridge, Samia Guita, Lisa Carey, Eva Schumacher, Theodora Goulioti, Thomas Meyskens, Joseph Gannon, Khadija Benlhassan, Giovanna Rossi, Eleni Xenophontos, Amal Arahmani, Amylou C. Dueck, Gautier Paux, Etienne Brain, David A. Cameron
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT1-04-01.
https://doi.org/10.1158/1538-7445.SABCS22-OT1-04-01
Published: 01 March 2023
View article titled, Abstract OT1-04-01: AMEERA-6: Phase 3 Study of Adjuvant Amcenestrant Versus Tamoxifen for Patients With Hormone Receptor-Positive Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity
Journal Articles

Abstract GS4-09: Quality of life results from OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)-adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER-2 negative early breast cancer

Patricia A Ganz, Hanna Bandos, Tanja Spanic, Sue Friedman, Volkmar Müller, Sherko Kümmel, Suzette Delaloge, Etienne Brain, Masakazu Toi, Hideko Yamauchi, Eduardo-Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuangui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Christine Campbell, Judy E Garber, Charles E Geyer, Jr, Andrew NJ Tutt, On behalf of the OlympiA Trial Steering Committeeand Investigators
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): GS4-09.
https://doi.org/10.1158/1538-7445.SABCS21-GS4-09
Published: 15 February 2022
View article titled, Abstract GS4-09: Quality of life results from OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)-adjuvant chemotherapy in patients with germline <em>BRCA1/2</em> mutations and high-risk HER-2 negative early breast cancer
Journal Articles

Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine

Giovanna Rossi, Michail Ignatiadis
Journal: Cancer Research
Cancer Res (2019) 79 (11): 2798–2804.
https://doi.org/10.1158/0008-5472.CAN-18-3402
Published: 03 June 2019
View article titled, Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine
Open the PDF for Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine in another window
Journal Articles

Abstract 2646: The liquid biopsy network in advanced breast cancer (ABC): Benchmarking the prognostic role of circulating tumor DNA (ctDNA) to the goal standard circulating tumor cells (CTCs) enumeration

Lorenzo Gerratana, Andrew A. Davis, Giovanna Rossi, Kimberly Strickland, Zhaomei Mu, Lisa Flaum, William J. Gradishar, Cesar Santa-Maria, Hushan Yang, Massimo Cristofanilli
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2646.
https://doi.org/10.1158/1538-7445.AM2018-2646
Published: 01 July 2018
View article titled, Abstract 2646: The liquid biopsy network in advanced breast cancer (ABC): Benchmarking the prognostic role of circulating tumor DNA (ctDNA) to the goal standard circulating tumor cells (CTCs) enumeration